Consensus guidelines recommend the consideration of testing for DICER1 in any patient with a childhood onset MNG or DTC, especially if in combination with macrocephaly, another tumour typical of DICER1 syndrome, or a first-degree relative with an MNG/thyroid carcinoma or DICER1 syndrome features [55]. This evidence concerns the gene DICER1 and toxic multinodular goitre.